90,000 people benefit from Exxon Mobil sponsored Africare Malaria prevention programme

former minister of Health, Prof. Isaac Adewole

 

PRESS RELEASE

 

 

Africare MALARIA prevention PROJECT DELIVERS MAJOR

IMPROVEMENTS IN MALARIA CONTROL

Pregnant women and children were key beneficiaries of multi-pronged project

 

Abuja, Nigeria  (March 12, 2018) — Africare, the premier NGO committed to helping African people build sustainable, healthy and productive communities, today released the results of a six-year malaria prevention program in Nigeria that was implemented with the support of ExxonMobil.

 

The Malaria Prevention in Mobil Producing Nigeria Supplier Communities (MAPS-C) project ran from 2011 through 2017 and was focused on four local government areas in Akwa Ibom and Rivers States (Eket, Ibeno, Bonny and Ogu/Bolo) reaching over 90,000 people.  Beneficiaries included children under five and pregnant women in households within these communities.

 

Among the top-line results of the evaluation of the MAPS-C project, it was found that:

 

  • The percentage of under-five children who received Artemisinin-based Combination Therapy (ACT) as treatment for malaria increased from 21% at the start of the project, to 74% in 2016
  • Percentage of persons with suspected malaria that were tested increased from less than 30% at the start of the project, to more than 90% in 2016.
  • The percentage of pregnant women who received two of the four WHO required preventive treatment doses with sulphadoxine-pyrimethamine (SP) increased from 29% in 2013 to 52% in 2016

 

“We are encouraged by the results of our multi-pronged approach and the support of our partners on the ground.   We feel confident that our work to increase community knowledge, improve practices of health care workers, and improve malaria treatment and care, will have a lasting impact on the goal to eliminate malaria.” said Africare President, Robert Mallett. “We are grateful to ExxonMobil for their support.”

 

Africare’s multi-pronged approach comprised four elements:

 

  1. Assess and Build Upon Existing Interventions to determine the effectiveness of previous malaria control efforts against the current project.
  1. Strengthen Synergies for Scale-Up of Results in Six Key Malaria Intervention Areas: including:
  • Case Management
  • Use of Insecticide Treated Nets (ITNs) by every household
  • Uptake of Intermittent Prophylaxis Treatment ( IPT)  for Pregnant Women
  • Public awareness and capacity of households and communities to effectively prevent, treat, and control malaria.
  • Malaria Seminars for MPN Suppliers and Vendors
  • Documentation and ongoing dissemination of best practices to inform, scale up and replicate successful interventions.
  1. Learn and Share Best Practices

 

The Africare MAPS-C project has helped advance our goals of working with partners to provide malaria prevention therapies to communities in Nigeria and helping to improve health infrastructure,” said Kevin Murphy, president of ExxonMobil Foundation.   “We were proud to support Africare in training health workers in electronic data capture and timely sharing of health information.”

About Africare

Africare is the premier Africa-focused non-governmental organization (NGO) working in partnership with African people to build sustainable, healthy and productive lives and communities, and to be a leading voice addressing African development and policy issues.

 

Media Contacts

Dr. Patrick Adah, Director of Programs, Africare. Tel (+234) (0)803 094 5138 Email: padah@africare.org

The Final Evaluation Report of the Malaria Prevention in MPN-Supplier Communities (MAPS-C) is available: https://www.dropbox.com/s/g9e5nmjwpjda11k/Final%20Evaluation%20Report%20MAPS-C%20Project-Final10Feb2017.doc?dl=0

Hi-resolution photographs and approved quotes from local officials and beneficiaries are available [see addendum provided] https://www.dropbox.com/s/95l8qed5hhp161i/QUOTES%203.ppt?dl=0
 

 

# # #

PBAT’s Oil and Gas Reforms

PBAT's Oil and Gas Reforms 2.3

NCC

FIRS

Be the first to comment

Leave a Reply

Your email address will not be published.


*